EPILEPSIA

Scope & Guideline

Charting new paths in epilepsy understanding.

Introduction

Explore the comprehensive scope of EPILEPSIA through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore EPILEPSIA in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0013-9580
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1909 to 1915, from 1937 to 1950, from 1952 to 1955, 1959, from 1961 to 2024
AbbreviationEPILEPSIA / Epilepsia
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "EPILEPSIA" focuses on advancing the understanding of epilepsy through the dissemination of high-quality research. It encompasses a wide range of topics related to the etiology, diagnosis, treatment, and management of epilepsy, as well as the psychosocial aspects associated with the condition.
  1. Clinical Research and Trials:
    The journal publishes studies on the efficacy and safety of new and existing antiseizure medications, surgical interventions, and other treatment modalities, emphasizing evidence from clinical trials.
  2. Neurophysiology and Biomarkers:
    Research on electroencephalographic (EEG) patterns, biomarkers, and neuroimaging techniques to enhance the understanding of seizure mechanisms and predict surgical outcomes is a significant focus.
  3. Genetics and Epigenetics:
    There is a strong emphasis on the genetic underpinnings of epilepsy, including studies on genetic variants, their phenotypic expressions, and implications for precision medicine.
  4. Pediatric and Adolescent Epilepsy:
    The journal addresses the unique challenges and treatment options for epilepsy in children and adolescents, with a focus on developmental and epileptic encephalopathies.
  5. Psychosocial Aspects and Quality of Life:
    Research exploring the impact of epilepsy on mental health, quality of life, and the social stigma associated with the condition is regularly featured.
  6. Innovative Technologies and Approaches:
    The journal includes studies on the use of wearable devices, artificial intelligence, and telemedicine in the management and monitoring of epilepsy.
The journal "EPILEPSIA" has shown a clear trend towards certain emerging areas of research that reflect the ongoing advancements in the understanding and treatment of epilepsy. These themes are gaining traction as researchers explore innovative approaches and technologies.
  1. Precision Medicine and Genetic Testing:
    There is a growing emphasis on tailored treatment approaches based on genetic testing, with studies investigating the implications of specific genetic variants on treatment efficacy and outcomes.
  2. Wearable Technology and Remote Monitoring:
    Research on the use of wearable devices for seizure detection and monitoring has surged, highlighting the potential for technology to enhance patient care and management.
  3. Neuroinflammation and Immune Mechanisms:
    Emerging studies are focusing on the role of neuroinflammation and immune responses in the pathogenesis of epilepsy, paving the way for novel therapeutic strategies.
  4. Psychogenic Non-Epileptic Seizures (PNES):
    There is an increasing interest in understanding and treating PNES, with a focus on the psychosocial dimensions and interventions that can improve patient outcomes.
  5. Long-Term Outcomes and Quality of Life Studies:
    Research examining the long-term effects of epilepsy treatments on quality of life and psychosocial well-being is gaining prominence, addressing the holistic needs of patients.

Declining or Waning

While "EPILEPSIA" continues to evolve, certain themes have shown a decline in research focus over recent years. These waning areas may reflect shifts in the broader scientific landscape or emerging priorities in epilepsy research.
  1. Generalized Epilepsy Research:
    There has been a noticeable decrease in studies focusing exclusively on generalized epilepsy syndromes, suggesting a shift towards more specific or complex forms of epilepsy.
  2. Traditional Pharmacological Approaches:
    Research centered around older antiseizure medications is declining, possibly due to the increasing interest in novel therapies and personalized medicine.
  3. Surgical Techniques in Established Epilepsy:
    Publications detailing traditional surgical techniques for epilepsy management are less frequent, as the field moves towards innovative and less invasive methods.
  4. Epidemiological Studies:
    Studies focused solely on the epidemiology of epilepsy, without a direct link to treatment outcomes or interventions, appear to be less prominent in recent issues.
  5. Longitudinal Studies without Interventions:
    There is a decrease in longitudinal studies that do not assess interventions or treatment changes, potentially due to a growing emphasis on actionable research.

Similar Journals

EUROPEAN JOURNAL OF NEUROLOGY

Shaping the Landscape of Neurological Research Since 1994.
Publisher: WILEYISSN: 1351-5101Frequency: 12 issues/year

EUROPEAN JOURNAL OF NEUROLOGY, published by WILEY, stands as a leading platform for the dissemination of innovative research and clinical developments in the field of neurology. With a robust impact factor and prestigious rankings, including being positioned as Q1 in both Neurology and Clinical Neurology categories, the journal plays a pivotal role in shaping neurological sciences from 1994 to 2024. Its Scopus rank highlights its importance, being in the 88th percentile for clinical neurology and 87th percentile for neuroscience. Located in the United Kingdom, the journal thrives as a vital resource for researchers, clinicians, and students dedicated to improving neurological health outcomes. Although it does not offer Open Access, its subscription-based model ensures high-quality peer-reviewed articles are accessible to a global audience, reflecting the continuous pursuit of excellence in neurological research and patient care.

Neurologia i Neurochirurgia Polska

Empowering Research, Transforming Practice
Publisher: VIA MEDICAISSN: 0028-3843Frequency: 6 issues/year

Neurologia i Neurochirurgia Polska is a prestigious Polish journal dedicated to advancements in the fields of neurology and neurosurgery, published by VIA MEDICA. With a rich history dating back to 1967, this journal serves as a critical platform for disseminating significant research findings and clinical practices that advance our understanding of neurological disorders and surgical interventions. Registered under ISSN 0028-3843 and E-ISSN 1897-4260, it boasts commendable rankings as reflected in its 2023 categorical quartiles: Q3 in Neurology (Clinical) and Q2 in Surgery, indicating its substantial impact within these domains. Furthermore, its Scopus rankings reveal that it is positioned at Rank #125/551 within Medicine-Surgery and Rank #187/400 in Medicine-Neurology (Clinical), showcasing its importance in academic and clinical circles. Although not currently open access, the journal remains accessible to readers and practitioners who seek to stay updated on innovative research and methodologies. The journal’s objective is to foster knowledge exchange and stimulate scientific dialogue among researchers, professionals, and students, thus shaping the future of neurology and neurosurgery in Poland and beyond. Located at UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND, it invites contributions that inspire and elevate the standards of medical practice.

EPILEPSY RESEARCH

Transforming research into clinical practice for epilepsy.
Publisher: ELSEVIERISSN: 0920-1211Frequency: 10 issues/year

EPILEPSY RESEARCH is a distinguished journal published by Elsevier, focusing on the dynamic field of neurology with a specific emphasis on epilepsy and related neurological disorders. Since its inception in 1987, the journal has become a vital platform for disseminating cutting-edge research, contributing significantly to the understanding of epileptic conditions and their clinical implications. With an impactful presence in the academic community, EPILEPSY RESEARCH currently holds a 2023 Q2 ranking in both the Neurology and Clinical Neurology categories, reflecting its commitment to high-quality, peer-reviewed content. The journal is indexed in SCOPUS, Ranking #173/400 in Clinical Neurology and #91/192 in Neuroscience, ensuring widespread visibility and academic engagement. Although not an open access publication, it provides critical insights, findings, and reviews that are essential for researchers, clinicians, and students alike, fostering advancements in epilepsy research and treatment. For any inquiries, the journal is based at Radarweg 29, 1043 NX Amsterdam, Netherlands.

Annals of Indian Academy of Neurology

Empowering Minds, Transforming Neurology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0972-2327Frequency: 4 issues/year

Annals of Indian Academy of Neurology is a premier open access journal dedicated to advancing the field of Neurology, serving as a vital resource for researchers, healthcare professionals, and students since its inception in 2006. Published by the esteemed Wolters Kluwer Medknow Publications, this journal has established itself within the academic community, boasting a Q3 quartile ranking in clinical neurology according to the 2023 category quartiles and a Scopus rank placing it in the 35th percentile among 400 comparable journals. With a focus on clinical advancements and research innovations in neurology, the journal aims to disseminate high-quality and impactful studies that address the complex challenges faced in the neurological landscape, particularly within the Indian context. The open access model ensures that the latest research is readily accessible to a global audience, thereby promoting collaboration and knowledge sharing within the neurosciences.

Journal of Pediatric Epilepsy

Fostering collaboration to enhance outcomes in pediatric epilepsy.
Publisher: GEORG THIEME VERLAG KGISSN: 2146-457XFrequency: 4 issues/year

The Journal of Pediatric Epilepsy, published by GEORG THIEME VERLAG KG, is a dedicated platform for advancing the understanding and treatment of pediatric epilepsy. With ISSN 2146-457X and E-ISSN 2146-4588, this journal provides vital insights and research findings relevant to clinicians, researchers, and students in the fields of neurology, pediatrics, and psychiatry. Although its coverage in Scopus was discontinued from 2012 to 2015, the journal continues to contribute to the body of knowledge within this critical area by focusing on novel therapeutic strategies, clinical studies, and case reports that address the unique challenges faced by children with epilepsy. The journal is committed to fostering collaboration and innovation in the treatment of pediatric seizure disorders, making it an essential resource for anyone dedicated to improving outcomes in this vulnerable population.

Neurology and Therapy

Unlocking Insights into Neurological Disorders and Treatments
Publisher: SPRINGER LONDON LTDISSN: 2193-8253Frequency: 2 issues/year

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

REVISTA DE NEUROLOGIA

Connecting Research and Clinical Practice in Neurology
Publisher: REVISTA DE NEUROLOGIAISSN: 0210-0010Frequency: 12 issues/year

REVISTA DE NEUROLOGIA is a distinguished academic journal focusing on the broad fields of neurology and medicine, published in Spain since its inception in 1959. The journal plays a vital role in disseminating significant research findings, clinical studies, and advancements in neurological science, catering to an audience of researchers, clinicians, and students alike. With an ISSN of 0210-0010 and an E-ISSN of 1576-6578, this quarterly publication has maintained its commitment to enhancing the understanding of neurological disorders and therapies through rigorous peer-reviewed articles. While currently not classified as open access, it is indexed in Scopus, holding a rank of #253 out of 400 in the category of Medicine (Neurology), reflecting its relevance in the field with a 36th percentile. The journal is positioned within the Q3 quartile for both Medicine (miscellaneous) and Clinical Neurology categories as of 2023. Based in Barcelona, Spain, it is a vital resource for anyone devoted to the advancement of knowledge and practice in neurology.

BRAIN & DEVELOPMENT

Fostering Innovation in Pediatric Brain Health
Publisher: ELSEVIERISSN: 0387-7604Frequency: 10 issues/year

BRAIN & DEVELOPMENT is a prestigious academic journal published by ELSEVIER, renowned for its pivotal contributions to the fields of developmental neuroscience, neurology, and pediatrics. Established in 1979, this journal has become an essential resource for researchers and clinicians alike, as it explores the complexities of brain development and associated neurological disorders in children. With an impactful focus on advancing scientific understanding, BRAIN & DEVELOPMENT is currently ranked in the Q3 quartile in Developmental Neuroscience and Clinical Neurology and Q2 in Pediatrics, reflecting its significance within the medical community. Its ISSN 0387-7604 and E-ISSN 1872-7131 underline its established presence in academic literature. While the journal does not offer open access options, it continues to be a key platform for disseminating new research findings and fostering innovation in the understanding of pediatric neurological health. The journal's commitment to quality research is further evidenced by its ongoing publication trajectory up until 2024, making it a vital source of knowledge for students, professionals, and educators in related fields.

JAMA Neurology

Transforming Understanding of Neurology through Open Access
Publisher: AMER MEDICAL ASSOCISSN: 2168-6149Frequency: 12 issues/year

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

NEUROLOGY

Exploring breakthroughs in neurological research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.